All Stories

  1. 2024 Update of the Asia‐Pacific League of Associations for Rheumatology ( APLAR ) Recommendations for Rheumatoid Arthritis Management
  2. MRI predictors of infectious etiology in patients with unilateral sacroiliitis
  3. Scoping review on remote disease monitoring in rheumatoid arthritis: does it actually help the patient?
  4. Primary care rheumatology: towards sustainable development in health
  5. 2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis
  6. 2022 American College of Rheumatology/EULAR Classification Criteria for Takayasu Arteritis
  7. Burden of osteoarthritis in India and its states, 1990–2019: findings from the Global Burden of disease study 2019
  8. Common mental disorders in South Asian patients with systemic sclerosis: a CIS-R-based cross-sectional study
  9. Biologics in Takayasu’s Arteritis
  10. Salivary free light chains and salivary immunoglobulins as potential non‐invasive biomarkers in primary Sjögren's syndrome
  11. Online academic community in the Asia‐Pacific countries: The paragon of a metamorphic world
  12. Magnetic Resonance Imaging evidence of Inflammation at Interphalangeal joint of Thumb — A distinct entity in psoriatic arthritis
  13. Correction to: In vitro effects of curcumin on proinflammatory cytokines and expression of their genes in minor salivary gland tissue of patients with Sjogren’s syndrome
  14. Update on pregnancy in Takayasu arteritis—A narrative review
  15. In vitro effects of curcumin on proinflammatory cytokines and expression of their genes in minor salivary gland tissue of patients with Sjogren’s syndrome
  16. Cotrimoxazole prophylaxis prevents major infective episodes in patients with systemic lupus erythematosus on immunosuppressants: A non-concurrent cohort study
  17. Update on Post-Streptococcal Reactive Arthritis: Narrative Review of a Forgotten Disease
  18. High expression of pro-inflammatory cytokine genes IL-1β and IL-1R2 upon TLR4 activation in Takayasu arteritis
  19. Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management
  20. Understanding immunopathological fallout of human coronavirus infections including COVID‐19: Will they cross the path of rheumatologists?
  21. Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment
  22. Obstetric and perinatal outcomes in pregnant women with Takayasu’s arteritis: single centre experience over five years
  23. Diagnostic performance of dry eye tests, serology and labial salivary gland biopsy in primary Sjogren's syndrome in an Indian setting
  24. Efficacy and safety of tocilizumab in treatment of Takayasu arteritis: A systematic review of randomized controlled trials
  25. Authors' response
  26. The relapsing polychondritis damage index (RPDAM): Development of a disease-specific damage score for relapsing polychondritis
  27. Recent advances in the management of Takayasu arteritis
  28. Vasculitis special issue
  29. A descriptive pilot study of mitochondrial mutations & clinical phenotype in fibromyalgia syndrome
  30. Letters from the outgoing and incoming Editor in Chief
  31. Study of clinical utility of antibodies to phosphatidylserine/prothrombin complex in Asian-Indian patients with suspected APS
  32. NMR-Based Serum Metabolomics of Patients with Takayasu Arteritis: Relationship with Disease Activity
  33. Sjögren’s, Renal Tubular Acidosis and Osteomalacia - An Asian Indian Series
  34. Podocyte Infolding Glomerulopathy (PIG) in a Patient With Undifferentiated Connective Tissue Disease: A Case Report
  35. Long-term outcome of 251 patients with Takayasu arteritis on combination immunosuppressant therapy: Single centre experience from a large tertiary care teaching hospital in Southern India
  36. High Secretion of Interleukin-6 and Increased MINCLE Receptor Expression Upon Exposure to Mycobacterial Cord Factor Analog Trehalose-6, 6-Dibehenate (TDB) in Patients with Takayasu Arteritis
  37. PAI1 mediates fibroblast–mast cell interactions in skin fibrosis
  38. Carbon dioxide Angiography-Guided Renal-Related Interventions in Patients with Takayasu Arteritis and Renal Insufficiency
  39. CXCL13 levels in serum but not in saliva are elevated in Asian Indian patients with primary Sjögren’s syndrome
  40. Head to head comparison of adverse effects and efficacy between high dose deflazacort and high dose prednisolone in systemic lupus erythematosus: a prospective cohort study
  41. Clinical Predictors of Outcome in Buerger’s Disease using BVAS and DEI.Tak Scoring Systems
  42. Magnetic resonance imaging (MRI) of feet demonstrates subclinical inflammatory joint disease in cutaneous psoriasis patients without clinical arthritis
  43. Study of serial serum myeloid-related protein 8/14 as a sensitive biomarker in Takayasu arteritis: a single centre study
  44. Y RNA derived small RNAs in Sjögren's syndrome: Candidate biomarkers?
  45. Utility of CT imaging in differentiating sacroiliitis associated with spondyloarthritis from gouty sacroiliitis: a retrospective study
  46. C-reactive protein gene polymorphisms (rs1205) in Asian Indian patients with Takayasu arteritis: Associations and phenotype correlations
  47. Primary Sjögren's syndrome in Asia: Yin and Yang?
  48. Design and evaluation of cryodevice, an easy to use apparatus for maintenance of optimum temperature during cryoglobulin assay
  49. Serum amyloid A as a marker of disease activity and treatment response in Takayasu arteritis
  50. Mycophenolate mofetil and deflazacort combination in neuropsychiatric lupus: a decade of experience from a tertiary care teaching hospital in southern India
  51. Interleukin-17F and interleukin-6 gene polymorphisms in Asian Indian patients with Takayasu arteritis
  52. Utility of Plain Radiographs in Metabolic Bone Disease – A Case-Based Pictorial Review from a Tertiary Centre
  53. TNFα blockers followed by continuation of sulfasalazine and methotrexate combination: a retrospective study on cost saving options of treatment in Spondyloarthritis
  54. Addition of second-line steroid sparing immunosuppressants like mycophenolate mofetil improves outcome of Immunoglobulin G4-related disease (IgG4-RD): a series from a tertiary care teaching hospital in South India
  55. Soluble-HLA-E: A follow up biomarker in Takayasu arteritis, independent of HLA-E genotype
  56. 403 Study of familial aggregation of autoimmune diseases in asian indian lupus patients (PROBANDS)
  57. Serum Cytokine Profile in Asian Indian Patients with Takayasu Arteritis and its Association with Disease Activity
  58. Egyptian tale from India: application of whole-exome sequencing in diagnosis of atypical familial Mediterranean fever
  59. Correlating MRI with clinical evaluation in the assessment of disease activity of Takayasu's arteritis
  60. Chikungunya Infection: a Global Public Health Menace
  61. Update on Pathogenesis of Sjogren's Syndrome
  62. Pulmonary hypertension in connective tissue diseases: an update
  63. Vitamin D Levels and Associations in Indian Patients with Primary Sjögren’s Syndrome
  64. Anti-C1q Antibody is Associated with Renal and Cutaneous Manifestations in Asian Indian Patients with Systemic Lupus Erythematosus
  65. Diagnostic accuracy of salivary and serum-free light chain assays in primary Sjögren's syndrome: a pilot study
  66. Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjögren Project Consortium
  67. High salivary soluble L-selectin and interleukin-7 levels in Asian Indian patients with primary Sjögren’s syndrome
  68. Psoriatic arthritis: lessons from imaging studies and implications for therapy
  69. Inflammation, metabolism and adipokines: toward a unified theory
  70. Effect of Macitentan on the Development of New Ischemic Digital Ulcers in Patients With Systemic Sclerosis
  71. MRI and ultrasound in rheumatoid arthritis
  72. ‘Outside the box’ genes, transcriptions and translations in Rheumatoid arthritis
  73. Younger patients with primary Sjögren’s syndrome are more likely to have salivary IgG anti-muscarinic acetylcholine receptor type 3 antibodies
  74. Gut inflammation and microbiome in spondyloarthritis
  75. Audiological Profile in Primary Sjögren’s Syndrome in a Tertiary Care Setting and its Clinical Implications
  76. Imaging in Takayasu arteritis
  77. Childhood-onset Takayasu arteritis: an update
  78. Proteomics in rheumatology
  79. The matrix protein Fibulin-5 is at the interface of tissue stiffness and inflammation in fibrosis
  80. Does the buck stop with the bugs?: an overview of microbial dysbiosis in rheumatoid arthritis
  81. Significantly reduced lymphadenopathy, salivary gland infiltrates and proteinuria in MRL-lpr/lprmice treated with ultrasoluble curcumin/turmeric: increased survival with curcumin treatment
  82. Reliability of Test for Manual dexterity in arthritis
  83. Therapeutic potential of curcumin and curcumin analogues in rheumatology
  84. Clinical Characteristics and Outcome of Primary Sjogren’s Syndrome: A Large Asian Indian Cohort
  85. Does low bone density influence symptoms and functional status in patients with fibromyalgia? Observations from rural South India
  86. Haematological manifestations of lupus
  87. Lessons from Asian lupus
  88. Which is worse in psoriasis - skin or joints?
  89. Are Indian patients with juvenile-onset ankylosing spondylitis taller than reference population ?
  90. Fingerprint Deposition on Nitrocellulose and Polyvinylidene Difluoride Membranes Using Alkaline Phosphatase
  91. SDS-PAGE to Immunoblot in One Hour
  92. Takayasu's Arteritis
  93. Sjögren’s, Renal Tubular Acidosis And Osteomalacia - An Asian Indian Series
  94. Cytokine gene polymorphisms in Asian Indian patients with Takayasu’s Arteritis (TA) – a single center study
  95. Office e-MRI: viewing joints from the inside
  96. Malignancy and autoimmunity: causally or casually related?
  97. Want to become an author, a reviewer or an editor? The choice is yours
  98. Cost of publication - Who pays for it?
  99. Childhood-onset Takayasu Arteritis — Experience from a Tertiary Care Center in South India
  100. Morphological analysis of peripheral arterial signals in Takayasu’s arteritis
  101. Genetics of juvenile idiopathic arthritis
  102. Special interest groups for ‘sustainable rheumatology’
  103. Role of vacuolar ATPase and Skp1 in Sjögren’s syndrome
  104. Conflict of interest, an unspoken reality in science
  105. ‘Bamboo spine’, a thing of the past?
  106. ‘Treat to target’ for rheumatoid arthritis in 2014 - time tested triple therapy or logical Biologics?
  107. Collaboration, the other name for research
  108. New perspectives and insights to Asian systemic lupus erythematosus: renal disease, genetic predisposition and disease activity
  109. Next generation evidence-based medicine: individualised, personalised and humanised
  110. Rapid control of disease activity by tocilizumab in 10 ‘difficult-to-treat’ cases of Takayasu arteritis
  111. Expression of iron-related proteins in the duodenum is up-regulated in patients with chronic inflammatory disorders
  112. Juvenile dermatomyositis management: moving but in need of a push
  113. Promptness? - Yes, Haste? - No
  114. Infliximab and occult Hepatitis B infection: to treat or not to treat?
  115. Rare Retinal Manifestations in Takayasu Arteritis
  116. A descriptive analysis of 14 cases of progressive-psuedorheumatoid-arthropathy of childhood from south India: Review of literature in comparison with Juvenile Idiopathic Arthritis
  117. Fibromyalgia or pseudo fibromyalgia? - We have to get it right
  118. Development and initial validation of the Indian Takayasu Clinical Activity Score (ITAS2010)
  119. A secosteroid and not just a food for thought
  120. It bites the heart or does it not?
  121. How safe is Celecoxib for Asian-Indian patients with rheumatic diseases?
  122. REGRESSION OF TAKAYASU RETINOPATHY AFTER REVASCULARIZATION OF OCCLUDED BRANCHES OF THE AORTIC ARCH BY PERCUTANEOUS ANGIOPLASTY
  123. Comparison of two referral strategies for diagnosis of axial spondyloarthritis: the Recognising and Diagnosing Ankylosing Spondylitis Reliably (RADAR) study
  124. Analysis of the WISP3 gene in Indian families with progressive pseudorheumatoid dysplasia
  125. Vasculitis assessment and Takayasu aorto-arteritis
  126. Pancreatitis in Systemic Lupus Erythematosus - Case Series from a Tertiary Care Center in South India
  127. Paraneoplastic Palmar Fasciitis in Carcinoma Breast
  128. Clinico-pathological correlation of non specific inflammation in bowel histology with joint manifestation in a tertiary center in South India
  129. Eosinophilic Esophagitis and Pharyngitis Presenting as Mass Lesion in a Patient With Inactive Rheumatoid Arthritis
  130. The study of Cutaneous Lupus Erythematosus Disease Area and Severity Index in Indian patients with systemic lupus erythematosus
  131. Supplementation of 1,25 dihydroxy vitamin D3 in patients with treatment naive early rheumatoid arthritis: a randomised controlled trial
  132. Superior mesenteric artery syndrome in an adult rheumatoid arthritis patient
  133. OCULAR MANIFESTATIONS OF TAKAYASU ARTERITIS
  134. Pneumorrhachis and pneumomediastinum in connective tissue disease-related interstitial lung disease: case series from a tertiary care teaching hospital in South India
  135. Outcome of patients with seronegative spondyloarthritis continuing sulphasalazine and methotrexate after a short course of infliximab therapy—experience from a tertiary care teaching hospital in South India
  136. Primary Sjögren’s Syndrome: Report from India
  137. Hypoperfusive and hypertensive ocular manifestations in Takayasu arteritis
  138. Parkinsonism Mimicking Rheumatoid Arthritis
  139. Immune responses to Epstein-Barr virus in individuals with systemic and organ specific autoimmune disorders
  140. Mycophenolate mofetil in Takayasu’s arteritis
  141. Infection and Systemic Autoimmune Rheumatic Diseases
  142. Rheumatic Diseases and the Eye
  143. Acute pancreatitis as the initial presentation in pediatric systemic lupus erythematosus
  144. Osteoporosis in ankylosing spondylitis
  145. Relapsing polychondritis—case series from South India
  146. Rare presentation of Takayasu's aortoarteritis after double valve replacement
  147. Wegener’s granulomatosis—a rare presentation
  148. High frequency ultrasonography of the Achille's tendon in the diagnosis of enthesopathy in patients with spondyloarthropathy
  149. Correlation between serum methotrexate concentrations and disease remission status in rheumatoid arthritis patients on triple disease-modifying antirheumatic drug therapy
  150. Management of patients with fibromyalgia using biofeedback: A randomized control trial
  151. Update on Antiphospholipid Syndrome (APS)
  152. Dowling-Degos disease, hidradenitis suppurativa and arthritis in mother and daughter
  153. Management of Kikuchi Disease Using Glucocorticoids
  154. A case of Sjogren syndrome presented as interstitial pneumonia
  155. Absence of Antibody to HTLV-1 in Sera of Asian Indian Patients with Systemic Autoimmune Rheumatic Diseases
  156. Humoral immunity to Ro52 is not associated with the Ro52 9571 C/T polymorphism in Australian patients with primary Sjögren's syndrome
  157. Drug Resistant Tuberculosis in Diabetes Mellitus: A Retrospective Study from South India
  158. Lipodystrophy and connective tissue panniculitis
  159. Polymyositis - an unusual manifestation of chronic graft-versus-host disease
  160. EFFECT OF DIABETES MELLITUS ON SALIVARY PARACETAMOL ELIMINATION